Clinical Trial Compliance
Making sure clinical trial participants have enough food is critical because nutrition directly impacts both their health and the reliability of study results. Here’s why it Matters for Standardization:
Consistency in Biological Responses
Food intake influences metabolism, immune function, and even how drugs are absorbed and processed. If some participants are well-fed and others are malnourished, their bodies will respond differently to the investigational drug or therapy. That variability can mask or exaggerate effects, making results harder to interpret.
Reducing Confounding Variables
Clinical trials aim to measure the effects of one intervention. Poor or inconsistent nutrition introduces a powerful confounding factor—meaning observed differences could be due to food insecurity rather than the treatment. Ensuring adequate food standardizes baseline conditions so changes are more likely linked to the intervention.
Participant Safety & Retention
Undernourished participants are more vulnerable to side effects and may drop out of studies due to illness, fatigue, or inability to comply with trial requirements. Providing food improves retention, reduces adverse events linked to malnutrition, and demonstrates ethical responsibility toward participants’ well-being.
Ethical and Regulatory Compliance
Ethics boards and regulators require that participants are not exposed to unnecessary harm. Allowing food insecurity during a trial could be seen as neglectful, particularly if it affects vulnerable populations. Providing food ensures compliance with Good Clinical Practice (GCP) standards.
Improved Data Quality
Standardized nutrition helps ensure that biological markers (e.g., blood sugar, cholesterol, inflammatory markers) reflect the treatment, not differences in diet. This leads to cleaner datasets, stronger statistical power, and more credible findings for FDA or peer review.
